New Blood Test Predicts How Ovarian Cancer Cells To Which Treatment
Saturday, September 6, 2014 - 09:20
in Health & Medicine
A new blood test could allow doctors to predict which ovarian cancer patients will respond to particular types of treatment. The test could be developed and used in hospitals within the next few years. It would mean medics could see which patients could benefit from blood vessel-targeting drugs - such as bevacizumab - in addition to conventional therapy. Meanwhile, others who are not going to benefit would be spared the time and side effects associated with having the drug. The test would also help to reduce the cost to the NHS. Ovarian cancer has seen little increase in survival rates over the last few decades and scientists are seeking new treatment strategies to improve the standard approach of surgery and chemotherapy. read more